Cong workers attempt to lay siege to BSY’s house; face resistances from BJP leaders

Bengaluru, Feb 5: The Karnataka government on Tuesday launched the Janasevaka scheme in a few municipal corporation wards to ensure home delivery of various services like ration cards, senior citizen identity and health cards.

The scheme, which was launched by Chief Minister B S Yediyurappa, will pertain to 53 services involving 11 departments.

"Janasevaka under the Sakala scheme is a programme to avail the benefits of government schemes at the doorstep. Our objective is to make the lives of the citizens of Karnataka easy by launching this scheme," the Chief Minister said. Sakala aims to ensure in-time delivery of government services to citizens by practising innovative and efficient management systems through capacity building in government and empowering citizens to exercise their right to service.

Minister for Sakala and Primary and Secondary Education S Suresh Kumar said: "The scheme that was implemented in Dasarahalli area on a pilot basis will now be extended to Mahadevapura, Bommanahalli and Rajajinagar areas."

He added that it will benefit the senior citizens of the city.

If the scheme works well, it will be implemented across Bengaluru in all the 27 assembly segments, Kumar said, adding that based on the experiment in Bengaluru, it will be extended to Mysuru, Mangaluru and Hubballi-Dharwad.

Under the scheme, there will be one volunteer in each ward. These volunteers have been outsourced. A toll-free helpline has been set up for this scheme which will work from 8 am to 8 pm.

A sum of Rs 115 will be charged to provide the home delivery services.

In addition to it, the Karnataka government has also decided to seek information under the RTI Act easy by making it online.

People can apply from home by paying the fee online. This will make the process hassle-free, the Chief Minister said.

Bengaluru, Apr 19: The Karnataka government on Saturday ordered 2 lakh Personal Protective Equipment (PPE) kits from DHB Global and 1 lakh from other major pharmaceuticals, for the healthcare warriors treating coronavirus patients.

According to the State Health Department, these PPEs have 10 components as per global standards like a face mask to prevent healthcare professional from any liquid sprays, goggles for additional safety, N95 masks for protection of nasal and mouth areas, surgical masks, nitrile gloves, coverall suit, shoe cover, waste disposable bag, plastic apron, and protective gear.

Each of the products should have the relevant certificate from the Food and Drug Administration (USFDA) or equivalent certification.

New Delhi, Jun 11: The Department of Pharmaceuticals has given its nod for lifting of ban on the export of hydroxychloroquine, Union Minister D V Sadananda Gowda said on Wednesday.

India had banned export of hydroxychloroquine on March 25, with some exceptions, amid views in some quarters that the drug could be used to fight COVID-19. On April 4, it completely banned the exports without any exception.

"Department of Pharmaceuticals has approved the lifting of ban on export of Hydroxychloroquine API as well as formulations. Manufacturers except SEZ/EOU Units have to supply 20 per cent production in the domestic market," the minister of chemicals and fertilisers said in a tweet.

The Directorate General of Foreign Trade (DGFT) has been asked to issue formal notification in this regard, he added.

In another tweet, Gowda said he held discussions with representatives of pharma companies along with some of his ministerial colleagues on the challenges being faced by the industry and on the roadmap to boost exports.

"Had detailed discussion with representatives of pharma companies & association, stakeholder Ministries along with Hon Ministers @piyushGoyal  ji, @HardeepSPuri  ji, & @MansukhMandviya  ji on entire gamut of challenges faced by the industry as well as strategies to boost pharma export," Gowda tweeted.

India exported hydroxychloroquine API (active pharmaceutical ingredient) worth USD 1.22 billion in April-January 2019-20.

During the same period, exports of formulations made from hydroxychloroquine was at USD 5.50 billion.